Jungla Inc. Jungla combined functional genomics, biophysics, cellular engineering, and machine learning to generate scalable molecular evidence for interpreting genetic variants.
Products & media
Functional Modeling Platform
A cloud-distributed molecular-evidence platform combining functional genomics, biophysics, cellular engineering, machine learning, and clinical knowledge to interpret genetic variants at scale.
Cosigns
Jay RughaniPartner at Andreessen Horowitz
“We need tech for *computational* clinical genetics & genomics interpretation...and @junglainc can help!”
Carlos L. ArayaScientist and entrepreneur | Cofounder & CEO, Alloz Inc.
“At Jungla, we are continuously applying and combining advances in molecular, cellular, and computational technologies to the complex work of genetic variant interpretation with the goal of making it easier to conduct the highest quality genetic interpretation at scale.”
Arvind GuptaPartner at Mayfield investing in planetary health; Founder and Venture Advisor at IndieBio; author of Decoding the World.
“Together, Invitae and Jungla will accelerate the final interpretation step in genetic testing to help millions of people understand themselves better.”
Team
Founders
2 people
Company history
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Data current as of July 2019
Leads
Participating Firms
Angels